Skip to main content
Fig. 3 | Substance Abuse Treatment, Prevention, and Policy

Fig. 3

From: The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial

Fig. 3

Pen’s parades of FSS-9 sum scores at baseline and EOT12 (N = 276). Legends: The figures display participants who received integrated and standard HCV treatment. The graphs demonstrate the FSS-9 sum scores at baseline/prior to the HCV treatment and EOT12. The red line represents the FSS-9 sum scores at baseline when the participants are in sorted order by FSS-9 sum scores (from lowest (left) to highest (right) score). The blue spikes demonstrate the FSS-9 sum score at EOT12. The length of the spikes mark the changes in the FSS-9 sum score from baseline to EOT12. Participants without spikes did not complete FSS-9 assessment at EOT12. The dotted line demonstrates the cut-off value for severe fatigue (36 points). EOT12: 12 weeks after the end of treatment; FSS-9: Nine-item Fatigue Severity Scale. EOT12: 12 weeks after the end of treatment; FSS-9: Nine-item Fatigue Severity Scale

Back to article page